In this presentation, Blue Valentine, provides an overview of Xylazine, related withdrawal and overdose risk, and supportive care pearls. Furthermore, Blue discusses harm reduction strategies and preventative methods for safe… […]
Keyword: od
Substance Use Data Among American Indian/Alaska Natives | February 21, 2023
In this presentation, Michael Mudgett, reviews the latest substance use epidemiology data among American Indian/Alaska Natives at the IHS regional and national level. […]
Read More… from Substance Use Data Among American Indian/Alaska Natives | February 21, 2023
New Data: Buprenorphine and Benzodiazepine Overdose Risk | November 2, 2022
In this presentation, Dr. Jasen Christensen, DO, discusses how the addition of buprenorphine changes overdose risk, explains the affect of buprenorphine on risk for benzodiazepine overdose and describes the use of Clonidine in… […]
Read More… from New Data: Buprenorphine and Benzodiazepine Overdose Risk | November 2, 2022
Expanding Naloxone Access | June 21, 2022
In this presentation, LT Xiao Hong (Gina) Huang, PharmD & LT Tina Varughese, PharmD discuss opioid overdose, compare and contrast naloxone formulations, and introduce the implementation of pharmacy-managed naloxone clinics… […]
Fentanyl’s Rising Presence in Oregon | January 4, 2022
In this presentation, guests from Overdose Data to Action: Oregon HOPE discuss the rising prevalence of fentanyl in substances used, share insight from interviews with persons who are currently exposed… […]
Read More… from Fentanyl’s Rising Presence in Oregon | January 4, 2022